References
- Vilela RC, Vilela L, Vilela P, et al. Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol. 2014 Jun;34(3):707–721. doi:10.1007/s10792-013-9854-z.
- Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008 Sep;115(9):1501–1502. doi:10.1016/j.ophtha.2008.02.027.
- Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:10.1128/CMR.00113-16.
- Mínguez E, Ángeles M, Buey D, Cristóbal JÁ. Capítulo 159 - Tratamiento de la endoftalmitis en cirugía de la catarata. In: Lorente R, Mendicute J, eds. Cirugía del Cristalino. Sociedad Española de Oftalmología. 2008.
- Smith TC, Benefield RJ, Kim JH. Risk of fungal endophthalmitis associated with cataract surgery: a mini-review. Mycopathologia. 2015;180(5–6):291–297. doi:10.1007/s11046-015-9932-z.
- Kurtzman CP. Phylogeny of the ascomycetous yeasts and the renaming of Pichia anomala to Wickerhamomyces anomalus. Antonie Van Leeuwenhoek. 2011 Jan;99(1):13–23. doi:10.1007/s10482-010-9505-6.
- Fernández-Ruiz M, Guinea J, Puig-Asensio M, et al. CANDIPOP project; GEIH-GEMICOMED (SEIMC) and REIPI. Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain. Med Mycol. 2017 Feb 1;55(2):125–136. doi:10.1093/mmy/myw055.
- Zhang L, Xiao M, Arastehfar A, et al. Investigation of the emerging nosocomial Wickerhamomyces anomalus infections at a Chinese Tertiary Teaching Hospital and a systemic review: clinical manifestations, risk factors, treatment, outcomes, and anti-fungal susceptibility. Front Microbiol. 2021 Oct 6;12:744502. doi:10.3389/fmicb.2021.744502.
- Jung J, Moon YS, Yoo JA, Lim J-H, Jeong J, Jun J-B. Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center. J Microbiol Immunol Infect [Internet]. 2018;51(6):794–801. doi:10.1016/j.jmii.2017.05.005.
- da Silva CM, de Carvalho Parahym AMR, Leão MPC, de Oliveira NT, de Jesus Machado Amorim R, Neves RP. Fungemia by Candida pelliculosa (Pichia anomala) in a neonatal intensive care unit: a possible clonal origin. Mycopathologia. 2013;175(1–2):175–179. doi:10.1007/s11046-012-9605-0.
- Kamoshita M, Matsumoto Y, Nishimura K, et al. Wickerhamomyces anomalus fungal keratitis responds to topical treatment with antifungal micafungin. J Infect Chemother [Internet]. 2015;21(2):141–143. doi:10.1016/j.jiac.2014.08.019.
- Park KA, Ahn K, Chung ES, Chung TY. Pichia anomala fungal keratitis. Cornea. 2008;27(5):619–620. doi:10.1097/ICO.0b013e318166c442.
- Esgin H, Bulut E, Örüm Ç. Candida pelliculosa endophthalmitis after cataract surgery: a case report. BMC Res Notes. 2014;7(1):7–9. doi:10.1186/1756-0500-7-169.
- Kurtzman CP. Chapter 80 - Wickerhamomyces. In: Kurtzman CP, Fell JW, Boekhout T, eds. The Yeasts. 5th ed. Elsevier; 2011:899–917.
- Stavrou AA, Pérez-Hansen A, Lackner M, Lass-Flörl C, Boekhout T. Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts. Med Mycol. 2020 Oct 1;58(7):987–995. doi:10.1093/mmy/myaa005.
- Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122(1):42–47. doi:10.1001/archopht.122.1.42.
- Kim DY, Moon HI, Joe SG, Kim JG, Yoon YH, Lee JY. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea. J Korean Med Sci. 2015 Jul;30(7):960–964. doi:10.3346/jkms.2015.30.7.960.
- Sen S, Lalitha P, Mishra C, et al. Post-cataract surgery fungal endophthalmitis: management outcomes and prognostic factors. Ocul Immunol Inflamm. 2021 Nov 17;29(7–8):1530–1536. doi:10.1080/09273948.2020.1737143.